Katrine Lykke Albertsen - JoVE Visualize

Showing results (1-10 of 2) with videos related to

Pageof 1

Sort By:

Lifetime Data Analysis|July 5, 2019

Prevalent cohort studies and unobserved heterogeneityNiels Keiding, Katrine Lykke Albertsen, Helene Charlotte Rytgaard, et al.

Dermatology and Therapy|July 18, 2025

The Tralokinumab Pre-Filled Pen Improved Atopic Dermatitis Signs and Symptoms and Was Well Tolerated in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A 16-Week, Open-Label, Single-Arm Phase 3 Study (INJECZTRA)Jennifer Soung, Vivian Laquer, Matthew Zirwas, et al.

Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:

Pageof 1

Lifetime Data Analysis|July 5, 2019

Prevalent cohort studies and unobserved heterogeneityNiels Keiding, Katrine Lykke Albertsen, Helene Charlotte Rytgaard, et al.

Dermatology and Therapy|July 18, 2025

The Tralokinumab Pre-Filled Pen Improved Atopic Dermatitis Signs and Symptoms and Was Well Tolerated in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A 16-Week, Open-Label, Single-Arm Phase 3 Study (INJECZTRA)Jennifer Soung, Vivian Laquer, Matthew Zirwas, et al.

Pageof 1